Italfarmaco is a multinational group company, founded in 1938 in Italy, operating in over 40 countries in the world in pharmaceutical and chemical-pharmaceutical industries. Having more than 2.100 employees worldwide, Italfarmaco Group’s latest annual sales exceeded 500 million in Euros. The products, with highly therapeutic content, are mainly focus on cardiovascular, immune-oncology, gynecology, osteoporosis and neurological treatments. The Group obtained state-of-art manufacture plants in Italy, Spain, Brazil and Chile. Italfarmaco Group stands out for its commitment to R&D, mainly on researching cardiovascular diseases, oncology and immunology. One of the priorities of Italfarmaco Group is to expand its product portfolio in consolidation with the development of international markets through: - Increase in investment in R & D to develop innovative products. - Enhancement of commercial partnerships with pharmaceutical companies worldwide. - Creation of new subsidiaries and joint ventures worldwide. In Vietnam, the newly opened Representative Office of Lifepharma SpA HCMC represents Italfarmaco Group. Lifepharma/Itafarmaco products have been widely recognized in the Vietnam market and achieved top positions especially in the woman’s health area. To serve our customers and partners better, and due to the sustainable growth potential of the market, Lifepharma/Italfarmaco in Vietnam now is in the process of expansion. At Lifepharma/Italfarmaco Group, our ambition is to be a leading integrated global healthcare company, focused on patients and community. We are committed to use innovations to cure addressed health problems, prevent diseases and protect lives across the world. This has become inspiration for all of our employees who want to contribute to not only current social healthcare improvement but also to a better future for our next generations.